The legacy of the Tuskegee syphilis experiments for emergency exception from informed consent

Annals of Emergency Medicine

Volumn 41, Issue 1, 2003, Pages 79-81

  Schmidt, Terri A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE;

CLINICAL RESEARCH; COMMUNITY CARE; EMERGENCY TREATMENT; HUMAN; INFORMED CONSENT; LEGAL ASPECT; NOTE; PATIENT RIGHT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; SAFETY; SYPHILIS; TUSKEGEE SYPHILIS; UNITED STATES;

EID: 0037228968     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.17     Document Type: Note

References (9)

1. US Food and Drug Administration, Title 21 CFR (61 FR 51528); October 2, 1996.
2. Biros MH, Fish SS, Lewis RJ. Implementing the Food and Drug Administration's final rule for waiver of informed consent in certain emergency research circumstances. Acad Emerg Med. 1999;6:1272-1282.
3. Shah AN, Sugarman J. Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med. 2003;41:72-78.
4. Webster's II New Riverside University Dictionary. Boston, MA: The Riverside Publishing Company; 1988.
5. Hawkins D. The Science and Ethics of Equality. New York, NY: Basic Books; 1977.
6. Adams JG, Wegener J. Acting without asking: an ethical analysis of the Food and Drug Administration wavier of informed consent for emergency research. Ann Emerg Med. 1999;33:218-223.
7. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 4th ed. New York, NY: Oxford University Press; 2001.
8. Jones JH. Bad Blood: The Tuskegee Syphilis Experiment. New York, NY: The Free Press;1993.
9. Levine MP. Bad blood: the health commissioner, the Tuskegee experiment and AIDS policy. The New York Native. March 28-April 10, 1983:18.